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Abstract 
 
We review evidence supporting the role of early life programming in the 
susceptibility for adult neurodegenerative diseases while highlighting questions and 
proposing avenues for future research to advance our understanding of this 
fundamental process. The key elements of this phenomenon are chronic stress, 
neuroinflammation triggering microglial polarization, microglial memory and their 
connection to neurodegeneration. We review the mediating mechanisms which may 
function as early biomarkers of increased susceptibility for neurodegeneration. Can we 
devise novel early life modifying interventions to steer developmental trajectories to their 
optimum? 
 
 
Keywords: pregnancy stress; neuroinflammation; early life; glia; Alzheimer's; 
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1. Introduction 
 
In this focused review, we propose that susceptibility to adult neurodegenerative 
diseases is programmed in the womb, and early postnatal preventive measures may 
reduce the risk. We delineate the key mechanisms and players mediating this 
phenomenon, a foundation for preventive strategies. First, we discuss what are likely 
the most common two insults taking place during fetal development and imprinting upon 
fetal brain: chronic pregnancy stress and inflammation. We propose that such imprinting 
is mediated via the microglial plasticity resulting in memory properties and that such 
memory may increase susceptibility to neurodegenerative diseases in adult life. We 
review the animal models required for studying and testing the mechanisms. The 
proposed concept requires a discussion of microglial plasticity and mechanisms by 
which in utero insults influence the dynamic process of microglial-neuronal interactions 
in the developing brain. The role of microglia in adult neurodegenerative disorders is 
discussed and this concept is brought back to the perinatal origins of adult susceptibility 
to neurodegeneration. Finally, we discuss how our present understanding of the 
mechanisms of microglial memory formation may inform novel modifying treatments to 
steer developmental trajectories to their optimum. 
 
2. Programming of fetal brain development by chronic stress exposure: the 
concept 
 
The complex development of the nervous system is characterized by essential 
processes like cell proliferation, migration and differentiation that follow a tightly 
regulated program at well-coordinated time points to ensure the establishment of brain 
structures and functions (Andersen 2003). During this developmental process, the 
organisms may be exposed to insults and environmental influences that might be critical 
for later susceptibility to diseases. Several models have been proposed to explain how 
this exposure to insults in utero and/or during early postnatal stages affects the 
development of target organs, disrupts homeostasis and increases the risk for diseases 
manifested in later life. Based on his studies on adult cardiovascular disorders, Barker 
proposed the hypothesis of the Fetal Basis of Adult Diseases (FeBAD) (Barker 1993) . 
FeBAD suggests that the fetus responds to the maternal health status mounting 
adaptive responses for survival. Stemming from Barker´s hypothesis, several other 
models have been proposed (Gluckman and Hanson 2006, Ben-Ari 2008, Gluckman, 
Hanson et al. 2010) prompting Van den Bergh to formulate the hypothesis of the 
“Developmental Origins of Behavior, Health and Disease” (DOBHaD), which integrates 
early brain and behavioral development with new insights from the field of epigenetics 
(Van den Bergh 2011).  
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Taken together, these models point to the concept that adult health and behavior 
are programmed in utero; and they are shaped postnatally throughout lifetime through 
new exposures. This continuous programming is mediated by epigenetic mechanisms 
to which we will return in Section 6.  
Perinatal stress is a known powerful driver of an individual’s spatiotemporal 
epigenome and integrative physiological responses: different cell types and organs - 
particularly the brain - elicit specific stress responses at different developmental stages 
due to genomic-/epigenomic-environmental interactions (Metz, Ng et al. 2015, Conradt, 
Adkins et al. 2018, Frasch, Lobmaier et al. 2018).  On the integrative physiological scale 
in humans, chronic maternal stress in the early third trimester of gestation can program 
heart rate regulatory systems in the fetus to be entrained by maternal heart rate 
fluctuations. This phenomenon is not seen in control subjects with low levels of stress 
as measured by Cohen perceived stressed scale (PSS-10) (Lobmaier S. 2019). More 
generally, such relative coordination and entrainment phenomena are well-described in 
the weakly coupled nonlinear dynamical systems, such as the complex physiological 
systems (Scott Kelso, Holt et al. 1981, Hoyer, Frasch et al. 2001).  
Despite these pilot reports in human cohorts, much of the evidence on the effects 
of perinatal stress on adult life has been gathered from animal studies (Frasch, Baier et 
al. 2018). We believe that animal models will continue to be indispensable to investigate 
the alterations of glial-neuronal development under various insults, including perinatal 
stress, to understand their mechanistic contribution to increased susceptibility to adult 
neurodegenerative diseases.  
 
3. Animal models of perinatal stress reveal links to early life neuroinflammation 
and neurodegeneration 
 
The last twenty years have witnessed an exponential increase in publications 
related to the effect of perinatal stress on offspring neurodevelopment both in animal 
models and in humans (Jawahar, Murgatroyd et al. 2015, Van den Bergh, van den 
Heuvel et al. 2017, Frasch, Baier et al. 2018). A detailed description of the factors that 
might lead to perinatal stress has been summarized before (Frasch M 2017). Broadly, 
these factors are comprised of a vast number of modifiable and nonmodifiable 
influences that the mother-child dyad might experience pre- and/or postnatally. The 
modifiable factors include under and overnutrition, substance abuse, drugs intake, 
intrauterine growth restriction or infection. The nonmodifiable factors include wars, 
famines, and natural disasters. Perinatal stress includes both, models of prenatal stress 
(PS) (Hubacek, Pitha et al. 2000) and postnatal stress; the latter are often referred to as 
Early Life Stress (ELS) (Jawahar et al, 2015). Note that in this review we reserve the PS 
abbreviation to prenatal stress. 
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 Animal models of PS have been designed to transfer the stress experienced by 
the mother to the embryo or fetus in utero by exposing the pregnant dam to stressors 
during different gestational phases (Huizink, Mulder et al. 2004, Mastorci, Vicentini et al. 
2009, Bock, Wainstock et al. 2015). Similarly, animal models of ELS have been 
designed to mimic childhood adversities, mostly related to the quality of maternal care 
such as maternal neglect or maltreatment (Jawahar, Murgatroyd et al. 2015, McDonnell-
Dowling and Miczek 2018). 
Regardless of the type of stressor applied, its frequency, duration and 
gestational/postnatal period of application, most studies using animal models provided 
strong evidence that exposure to insults during the prenatal period or during early 
postnatal development turns the offspring vulnerable to disease in later life. The 
consequences of such stressors are broad and can include learning and cognitive 
delays, cardio-metabolic alterations, pro-inflammatory responses, neuroendocrine 
impairment and neurodegenerative disorders (Van den Bergh 2011, Modgil, Lahiri et al. 
2014, Heim, Entringer et al. 2019). An important example of this relationship is 
observed in the limited nesting and bedding model (Rice et al, 2008; Walker et al, 
2017), a specific paradigm of ELS related to maternal neglect and maltreatment which 
was shown to exacerbate the amyloid-E (AE) plaque burden in the hippocampus and the 
neuroinflammatory response to Aβ in aged transgenic APP/PS1 mice (Brunson, Kramar 
et al. 2005, Hoeijmakers, Ruigrok et al. 2017). Conversely, enhanced maternal care 
after postnatal handling reduces amyloid accumulation in the hippocampus ameliorating 
cognitive decline in the APPswe/PS1dE9 mouse model of Alzheimer's disease (AD) 
(Lesuis, van Hoek et al. 2017).  
Together, these observations led to the neurodevelopmental hypothesis of 
neurodegenerative disorders: an unfavorable environmental input during early life 
shapes adult neuroplasticity that might result in neurodegenerative processes 
(Schaefers and Teuchert-Noodt 2016, Fanni, Gerosa et al. 2018).  
This neurodevelopmental hypothesis is clearly related to the “two hits” hypothesis 
in which each of the environmental inputs is considered a “hit” and, after a certain 
latency period, a second trigger is necessary for the disease to develop (Lahiri, Maloney 
et al. 2009). Nowadays, the theory has gained consideration as the concept of “multiple 
hits” to better interpret the composite genetic and environmental interplay that 
contributes to the development of neurodegenerative diseases (Faa, Marcialis et al. 
2014, Davis, Eyre et al. 2016, Post, Lieberman et al. 2018).  
For example, prenatally stressed (“first hit”) adult rats exposed to an intrastriatal 
injection of 6-hydroxy-DA (6-OHDA) to damage dopaminergic neurons (“second hit”) 
show high levels of tyrosine hydroxylase (TH) positive cells in the ventral tegmental 
area (VTA) which are more susceptible to 6-OHDA. In addition, the number and 
asymmetry of neuronal nitric oxide synthase (nNOS)-expressing cells in the VTA and 
nucleus accumbens are altered in PS rats. These results suggest a deregulation 
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between dopaminergic and nitrergic systems in the VTA of PS rats, which responded to 
the neurotoxic aggression by increasing the number of nNOS positive cells involved in 
neuroprotection of TH positive cells (Baier et al., 2014). 
PS affects both neuronal and glial cells, which show severe alterations in   
morphology and neurotransmitter systems. Adult male offspring of stressed rat dams 
exhibits long-lasting astrogliosis with reduced dendritic arborization (Barros, Duhalde-
Vega et al. 2006). This is accompanied by an increase of ionotropic and metabotropic 
glutamate receptors in the frontal cortex (FCx), striatum and hippocampus (Berger, 
Barros et al. 2002). In addition, there is an elevation in vesicular vGluT1-transporter in 
the FCx and GLT1 in hippocampus, associated with an increased glutamate uptake 
capacity in the FCx (Adrover, Pallares et al. 2015) and alterations in nitric oxide 
synthase-expressing cells (Baier, Pallares et al. 2014). 
Furthermore, PS induces changes in the glutamatergic metabolism, such as 
reduction of glutamatergic neurotransmission in the ventral hippocampus (Marrocco, 
Mairesse et al. 2012) and sex-specific increase of glutamate-receptor expression 
(Zuena, Mairesse et al. 2008, Wang, Ma et al. 2016). In addition, enhanced microglial 
activation is evidenced by an increased expression of microglial markers (Slusarczyk, 
Trojan et al. 2015), increased number of microglial cells with large somas (Diz-Chaves, 
Pernia et al. 2012), and an acceleration of microglial differentiation into ramified forms in 
the pre-weaning offspring (Gomez-Gonzalez and Escobar 2010). 
In sum, piling evidence derived from the PS animal models shows significant 
reprogramming of the glutamatergic-nitric oxide-microglia metabolism in prenatally 
stressed offspring. This supports the notion that exposure to insults during the prenatal 
and/or early life period may shape the vulnerability to neurodegenerative disorders in 
later life. 
 
4. Microglial plasticity due to fetal and neonatal insults: a microglial memory 
programming mechanism for life 
 
Microglia are the resident macrophages of the central nervous system, involved 
in immune surveillance; synaptic pruning and phagocytosis of misfolded protein 
aggregates (Heppner, Ransohoff et al. 2015). 
The neuropsychological notion of memory is usually linked to the concept of 
neuronal plasticity, i.e., the ability of neuronal cells and neuronal ensembles to adapt to 
their environment, individually and collectively, and respond adaptively when re-
encountering the same or similar set of stimuli. Evidence is mounting that similar 
mechanisms operate in glial cells, particularly microglia. Beyond their role as the 
"conventional macrophages of the brain,” microglia have fundamental roles in  
synaptogenesis (Kettenmann, Hanisch et al. 2011). As we discuss in detail in the next 
section, aberrant glial-neuronal interactions are important players in early stages of AD 
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and other adult neurodegenerative diseases (Madhusudan, Vogel et al. 2013, Bilbo and 
Stevens 2017, Frasch, Burns et al. 2018). 
It is well known that excessive activation of ionotropic glutamate receptors 
causes excitotoxicity and promotes cell death, underlying a potential mechanism of 
neurodegeneration. In addition to the excitotoxicity and inflammatory processes that 
characterize neurodegenerative disorders, an emergent role has recently been 
discussed for the nitric oxide pathways in relation to the glutamate neurotoxicity 
(Manucha 2017). Glutamate receptors are also expressed in microglia and it has been 
postulated that a dysfunctional subunit GluA2 may accelerate glutamate neurotoxicity 
via release of proinflammatory cytokines from microglia in neurodegenerative diseases 
(Noda 2016). 
Overactivation of microglia with a memory of PS may inflict injury in adulthood. 
For example, PS paradigms such as models of depression affect the offspring later in 
life inducing behavioral changes in adult mice, elevated release of chemokines and a 
profuse microglial activation (Slusarczyk, Trojan et al. 2015). In addition, PS has been 
linked with an abnormal expression of the α7 nicotinic acetylcholine receptor 
(α7nAChR) in the male PS-exposed adult brain (Baier, Pallares et al. 2015). Prenatal 
exposure to maternal restraint stress, a form of PS, reduced protein levels of α7nAChR 
in the adult frontal cortex and hippocampus, key areas affected by the AD pathology 
(Jellinger and Attems 2013). Further studies are needed to associate cell type-specific 
expression of α7nAChR to PS as well to neuropathological and behavioral phenotypes 
in mid and late adulthood. 
Recent studies in mice also indicate the role of inflammation in shaping microglia 
and behavior in the aging offspring of stressed mothers. Early life exposure to 
lipopolysaccharides (LPS), a widely used model of inflammation caused by infection 
with gram-negative bacteria, results in differential location of activated microglia in the 
brain, with sustained alterations in hippocampal microglia that become hypersensitive to 
inflammatory markers. These changes endure throughout adulthood and have negative 
effects on memory and learning (Schaafsma, Basterra et al. 2017).  
In line with these LPS-based studies and independent of PS, infections of the gut 
may precede Parkinson’s disease (PD) by years or trigger it in an experimental mouse 
model (Matheoud, Cannon et al. 2019, Nerius, Doblhammer et al. 2019). The latter 
demonstrated involvement of glial cells in the pathogenesis of the autoimmune 
response resulting in a PD phenotype. These findings underscore the importance of the 
brain-gut axis for neurodegenerative diseases and the likely multi-hit nature of their 
etiology. The longest brain nerve connecting brain and body is the vagus nerve, an 
important substrate of cholinergic signaling, including peripheral signaling via the 
α7nAChR, the cholinergic anti-inflammatory pathway (Rosas-Ballina, Olofsson et al. 
2011). This brain-body connection begins in utero (Garzoni, Faure et al. 2013) and 
interruption of the vagus nerve signaling reduces the risk for PD (Liu, Fang et al. 2017). 
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Non-neuronal (i.e., non-vagus-nerve), humoral, lymphatic and blood-stream - mediated 
brain-gut pathways have also been discussed in linking enteral and cerebral 
homeostasis (Santos, de Oliveira et al. 2019).  
In addition to gut infections, chronic oral cavity infections have also been 
associated with an increased risk for AD, probably mediated by resident microglia 
responding to chronic systemic inflammation caused by periodontitis (Kamer, Craig et 
al. 2008, Wu and Nakanishi 2014).  
Are there common features of the reported studies that could be integrated into a 
microglial endophenotype that increases the risk for neurodegeneration in adulthood? 
Perhaps an immunosenescence perspective can help shed light on possible 
mechanisms of early-life programming of neurodegeneration (Fulop, Larbi et al. 2017). 
What distinguishes the centenarians that remain untouched from neurodegenerative 
conditions? The common denominator appears to be their subjective innate or acquired 
resilience (Krohne 2001, Franceschi and Bonafe 2003, Southwick S 2012). Is the 
subjective processing of uncertainty as "less or not stressful" a key to long life with 
reduced immunosenescence and hence delayed or no neurodegeneration (Peters, 
McEwen et al. 2017)?  
Peters et al. propose that there is a cerebral metabolic cost to processing 
uncertainty in information, a hallmark of chronic stress (Peters, McEwen et al. 2017). 
Early life inflammatory exposures reprogram fetal microglia toward a distinct 
immunometabolic phenotype defined by what teleologically appears to be energy 
preservation (Cao, Cortes et al. 2015). Taken together, does this implies that 
stress/uncertainty-imposed energy demands of information processing cannot be met 
fully by a stressed brain? Indeed, microglial senescence is discussed as a contributor to 
age-related neurodegeneration (Luo, Ding et al. 2010, von Bernhardi, Eugenin-von 
Bernhardi et al. 2015). Little is known about the control mechanisms governing the 
metabolic changes within the microglia which occur to meet the requirements of their 
phenotypic switch (Borst, Schwabenland et al. 2018). Similar to our findings in ovine 
fetal microglia in response to inflammation, metabolic changes do correlate with the 
ability of innate immune cells to show hallmarks of adaptive immune responses (Borst, 
Schwabenland et al. 2018).   
Is this immunometabolic endophenotype inherited multigenerationally via the 
DoHAD pathway of immunosenescence (Hanson, Cooper et al. 2016)? Fetal microglia 
and astrocytes exhibit memory of preceding insults (Cao, Cortes et al. 2015, Frasch 
2018, Cao, MacDonald et al. 2019). Does such plasticity and memory of experienced 
insults come at a cost of a reduced energy reserve for future hits? Does such reduced 
reserve translate into an increased susceptibility to adult neurodegenerative diseases 
(Paolicelli, Bolasco et al. 2011)?  
In summary, increasing support for mechanisms representing microglial memory 
emerge, as well as new questions as to whether these new players in the etiology of 
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neurodegenerative diseases also lend themselves as novel therapeutic targets which 
modulate the microglial memory by interfering with its programming. 
5. Role of Microglia in Adult Neurodegenerative disorders: early life origins 
 
Inflammation is a prominent axis of neuropathology common to most 
neurodegenerative disorders in adulthood. Stress has also been coming increasingly 
into focus as an important contributor, perhaps even as a trigger of clinical 
manifestation. The involvement of exacerbated microglia and astroglia reactivity in the 
pathophysiology of neurodegeneration is indisputable, but their precise roles and 
patterns of interaction with triggers such as inflammation or stress remain subject of 
ongoing research. 
  
Alzheimer’s disease, neuroinflammation and stress 
AD is a multifactorial neurodegenerative disorder that affects nearly 50 million 
people worldwide, representing the most prevalent form of dementia in older adults. AD 
is manifested clinically by progressive memory loss and a gradual decline in global 
cognitive function that interferes with daily living. At the neuropathological level, AD is 
characterized by accumulation of amyloid-E (AE) in amyloid plaques, phosphorylated 
Tau protein in neurofibrillary tangles, and progressive neuronal loss in the neocortex 
and the hippocampus (Querfurth and LaFerla 2010). 
Inflammation is a major feature of AD pathology (Gorelick 2010). Cytokines, 
chemokines and complement factors are found in the cerebrospinal fluid (CSF) and 
amyloid plaques in the brain of AD patients. Several epidemiological studies and clinical 
trials link inflammatory markers to dementia and cognitive impairment (Beard, Waring et 
al. 1998, Aisen, Schafer et al. 2003, Barber 2011). Moreover, the expression of 
inflammation-related genes varies as disease progresses, suggesting their role in 
pathophysiology (Bossers, Wirz et al. 2010). 
Ageing and neurodegeneration diminish microglial function, as evidenced by 
disruption of microglia-specific transcripts such as TREM2 and CD33 in AD brains 
(Clayton, Van Enoo et al. 2017). Interaction of microglia with AE plaques activates the 
pro-phagocytic phenotype (M2) to clear the aggregates. However, as the plaque burden 
increases in the brain overtime, microglia shift towards a pro-inflammatory phenotype 
(M1), triggering chronic inflammation and neuronal death (Tang and Le 2016). AE-
stimulated microglia show high levels of phagocytic markers such as AXL, CLEC7A, 
LGALS3, CD11C, TREM2, and TYROBP. While this activation may be beneficial for the 
clearance of protein aggregates, a hyperactive response to AE has been reported in the 
brains of early onset AD cases and may be associated with neuronal death (Yin, Raj et 
al. 2017).  
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While amyloid plaques are formed by the assemblage of large insoluble fibrils, 
smaller soluble AE oligomers can spread in the brain and are the most toxic forms that 
induce synaptic dysfunction (Smith and Strittmatter 2017). Interaction of these 
oligomers with TLR2 receptors in microglia induces a neurotoxic response with 
increased  transcription of pro-inflammatory molecules like iNOS and TNFD (Heurtaux, 
Michelucci et al. 2010, Liu, Liu et al. 2012). Furthermore, AE oligomers persistently 
activate the tyrosine kinase pathway sustaining the release of neurotoxic factors 
(Dhawan, Floden et al. 2012) and the upregulation of TNFD and cytokines IL-1 and  IL-6 
(Meda, Cassatella et al. 1995).  
Remarkably, studies in genetic mouse models of AD and indirect results in non-
human primates indicate that chronic stress increases Aβ-mediated neuronal toxicity or 
increases Tau accumulation or phosphorylation and tangle formation (Dong and 
Csernansky 2009). A sustained neuroinflammation was suggested as a link between 
the initial Aβ pathology and the later tangle formation (Kinney, Bemiller et al. 2018). 
Future animal studies need to examine whether removing the microglial memory of 
prenatal insults via PS or infection may halt or at least slow down the progression of the 
three core AD features, Aβ, tangles and the chronic inflammation and, ultimately, the 
behavioral dementia phenotype. 
 
Parkinson’s disease, neuroinflammation and stress 
 PD is the second most frequent neurodegenerative disorder of the elderly, 
characterized clinically by motor impairment, gait disturbance, tremor and increased risk 
to dementia. At the neuropathological level, PD brains present with an accumulation of 
of D-synuclein (D-syn) aggregates in Lewy body structures, mainly in the substantia 
nigra (SN) and loss of dopaminergic neurons (Spillantini, Schmidt et al. 1997, Takeda, 
Mallory et al. 1998, Burn 2006). PD is a multifactorial disorder where genetic and 
environmental factors converge to generate pathology, and more than 90% of cases are 
of sporadic origin. Emerging data supports that chronic neuroinflammation is highly 
prevalent in PD, and increased number of microglia and microgliosis have been 
reported in postmortem PD brains and transgenic animal models of PD (Watson, 
Richter et al. 2012, Doorn, Moors et al. 2014). Importantly, microgliosis is more evident 
in the vicinity of dopaminergic neurons primed for degeneration in the SN, hippocampus 
and cortex (McGeer, Itagaki et al. 1988, Banati, Daniel et al. 1998, Imamura, Hishikawa 
et al. 2003, Sawada, Imamura et al. 2006). Activated microglia produce high levels of 
pro-inflammatory molecules like TNFD, IL6, nitric oxide synthase (NOS) and 
cyclooxygenase-2 (COX-2) that contribute to the cell-specific vulnerability in PD (Hunot, 
Boissiere et al. 1996, Knott, Stern et al. 2000, Block, Zecca et al. 2007, Dufek, 
Rektorova et al. 2015). Indeed, a higher density of activated microglia was observed in 
nigral neurons of mice exposed to the pro-inflammatory bacterial LPS. This region-
specific response may render the SN more vulnerable to neuronal death than cells in 
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the cortex or hippocampus correlating with the disease pathology (Kim, Mohney et al. 
2000). 
Exacerbated neuronal death, on the other hand, can also trigger microglial 
activation thus feeding a deleterious loop. Substances which are produced by dying 
dopaminergic neurons that can activate microglia include α-syn aggregates, ATP, matrix 
metalloproteinase-3 (MMP-3) and neuromelanin (Wilms, Rosenstiel et al. 2003, 
Davalos, Grutzendler et al. 2005, Zhang, Wang et al. 2005, Kim, Choi et al. 2007). 
Notably, suppression of microglial activation alleviates the PD phenotype in mouse 
models, further supporting the role of these cells in the pathophysiology (Wu, Jackson-
Lewis et al. 2002). 
Last but not least, chronic stress, including ELS, has been reported to contribute 
to PD etiology, potentially triggering PD (Hemmerle, Herman et al. 2012, Djamshidian 
and Lees 2014, Dalle and Mabandla 2018).  
 
Innate immune system, ELS, inflammation and neurodegeneration in adult life 
The role of the innate immune system in AD has gained attention after several 
genome-wide association studies identified disease-associated genomic risk loci that 
map to immune response genes and genes expressed by microglia. A recent study 
identified 29 risk loci associated to 215 genes with potential of causing AD; many of 
them were highly expressed in immune-related cells, including microglia (Jansen, 
Savage et al. 2019). Among these, INPP5D; GPSM3; PILRA; MS4A6A; MS4A7; RIN3 
and HMHA1 are microglia-enriched genes expressed in brain regions relevant to AD 
and associated with Braak staging and as measure of disease progression (Kunkle, 
Grenier-Boley et al. 2019). Interestingly, two studies identified a single-nucleotide 
polymorphism (SNP) at the third intron in KAT8 as a new AD risk locus. Multiple 
variants in this locus influence KAT8 expression and methylation levels, thus also 
linking epigenetic changes to AD risk (Marioni, Harris et al. 2018, Jansen, Savage et al. 
2019). 
While evidence supports the role of neuroinflammation in disease causation, the 
mechanisms that trigger this process and how inflammation reaches the brain are still 
not fully understood. One plausible explanation is that AD involves systemic alterations 
rather than being restricted to the brain. The innate immune response system eliminates 
pathogens in a fast and non-specific reaction involving inflammation. In the periphery, 
this system is composed by neutrophils, monocytes/macrophages, dendritic cells and 
natural killer cells, while in the brain this function is fulfilled by the resident microglia 
(Guillot-Sestier, Doty et al. 2015, Crotti and Ransohoff 2016, Le Page, Dupuis et al. 
2018). Adaptive immunity, however, cannot be initiated directly in the brain. Once 
microglia are activated in response to an insult, secretion of cytokines and chemokines 
is increased, attracting circulating lymphoid and myeloid cells and thus establishing a 
communication between the brain and the systemic immune response mechanisms 
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(Ransohoff and Brown 2012). In addition, alterations in the brain blood barrier observed 
in most neurodegenerative diseases, facilitate the flow of inflammation-related 
molecules between the brain and the systemic circulation, enabling the cross-talk 
between these systems (Busse, Michler et al. 2017). Therefore, adverse events during 
early life may affect the communication between brain and periphery paving the road for 
inflammatory-initiated diseases during adulthood. 
Prenatal challenging of the immune system by exposure of mice to Poly I:C 
(polyriboinosinic–polyribocytidilic acid) during gestation as a model of viral infections,  
results in chronic elevation of inflammatory cytokines, higher levels of amyloid precursor 
protein (APP) in the hippocampus, increased Tau phosphorylation and defective 
working memory in old age animals - features directly associated with AD pathology. 
These alterations are accompanied by microglial activation and reactive gliosis 
suggesting that priming the microglial system during early life favors a chronic 
inflammatory state that seeds neurodegenerative changes in the adult (Krstic, 
Madhusudan et al. 2012). As emerging evidence links viral infections with AD pathology 
(Readhead, Haure-Mirande et al. 2018), a provocative question is whether early-life 
exposure to viruses may contribute to this increased risk for AD.  
Multiple environmental toxins, particularly agrichemicals, have been linked to 
increased risk for PD (Wang, Costello et al. 2011, Desplats, Patel et al. 2012) and in 
many cases inflammation seems to be the underlying mechanism. Emerging evidence 
suggests that infections during the prenatal life also impact PD susceptibility (Collins, 
Toulouse et al. 2012). Maternal infections like bacterial vaginosis may increase the risk 
of the neonate to develop PD, an effect apparently mediated by the rise in 
chorioamniotic LPS and TNF-α levels in infected pregnant women, that hinders the 
development of dopaminergic neurons (Okada, Matsuzaki et al. 1997, Ling, Gayle et al. 
2002). 
Similarly, prenatal exposure to LPS increases the vulnerability of rats to rotenone 
in later life, resulting in synergistic effects that increase loss of tyrosine-hydroxylase 
(TH) cells in the SN in comparison to LPS-naïve animals. Dopaminergic cell loss was 
associated with increased levels of TNF-α and reactive microglia (Ling, Chang et al. 
2004). Other studies also support the idea that viral infections in the prenatal 
environment can prime the organism to develop PD as adults, potentially due to 
changes in density and/or activation states of microglia. In utero exposure to the 
synthetic dsRNA analogue Poly I:C increases the production of pro-inflammatory 
cytokines in the brain of exposed rats (Cunningham, Campion et al. 2007). Importantly, 
these events aggravate neurodegeneration inducing severe decay of the nigrostriatal 
dopaminergic system in adult animals (Deleidi, Hallett et al. 2010, Field, Campion et al. 
2010). While the specific role of microglia in mediating prenatal infections, dopaminergic 
neuronal loss and PD risk is yet to be defined, taken together, these studies point at 
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inflammation as an important agent contributing to PD risk via a modulation of the 
microglial phenotype. 
 
6. Epigenetic mechanisms link prenatal adverse environment, microglial memory 
and activation with adult neurodegenerative disorders 
 
Epigenetic mechanisms that dictate chromatin accessibility, such as DNA 
methylation and post-transcriptional histone modifications, modulate gene expression 
and are dynamically regulated in post-mitotic neurons. As these mechanisms have 
crucial functions in memory formation and synaptic plasticity (Day and Sweatt 2010, 
Sen 2015, Cholewa-Waclaw, Bird et al. 2016), it is not surprising that alterations in 
epigenetic regulation play a role in neurodegeneration. For example, AD brains show a 
general decay in global methylation and acceleration of aging as measured by 
methylation markers, particularly in areas selectively vulnerable to pathology (Urdinguio, 
Sanchez-Mut et al. 2009, Mastroeni, Grover et al. 2010, Levine, Lu et al. 2015). In PD 
brains, we observed aberrant cytoplasmic localization of DNA methyl transferase 1 
(DNMT1) in neurons due to interaction with aggregated D-syn resulting in reduced 
global methylation, including genes associated with PD pathology (Desplats, Spencer et 
al. 2011). 
 
Epigenetic modulation of microglial memory due to inflammation 
Notably, epigenome-wide association studies in cognitively impaired subjects 
and AD cases identified significant changes in DNA methylation at 71 methylation sites 
across the genome, that correlated with AD pathology burden. Among the differentially 
methylated genes were ANK1 and RHBDF2 which are involved in the signaling cascade 
that modulates the activation of microglia and the infiltrating macrophages to release 
TNFα from the cell surface (De Jager, Srivastava et al. 2014). More recently, ANK1 was 
reported to be specifically upregulated in microglia isolated from the hippocampus of AD 
brains, without significant changes detected in neurons or astrocytes from the same 
samples (Mastroeni, Sekar et al. 2018). Therefore, methylation changes associated with 
AD pathology appear to regulate the activation of microglia and to play important roles 
in neuroinflammation. 
Interestingly, work using inducible AD mouse models showed that early stages of 
pathology are associated with dynamic changes in chromatin structure nearby immune 
response genes. These changes include increased accessibility for the ETS family of 
transcriptional regulators, like PU.1, which are implicated in activation of macrophages. 
When mapped to orthologous regions in the human genome, the enhancers activated in 
the mice hippocampus corresponded to immune cell expression quantitative trait loci, 
further implicating immune processes in AD predisposition, and the involvement of 
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chromatin remodeling in triggering inflammatory responses (Gjoneska, Pfenning et al. 
2015).  
As mentioned before, another microglial factor, TREM2, has gained attention in 
AD research following the identification of genetic variants in this gene associated with 
increased disease risk (Jin, Benitez et al. 2014). TREM2 is expressed by activated 
microglia and presents with differential DNA methylation in AD brains (Smith, Smith et 
al. 2016) supporting a role for the epigenetic machinery in the modulation of the 
microglial transcriptome that may cause neurodegeneration.  
Key genes at almost every level of the inflammation response appear to be 
regulated by DNA methylation, including IL-2, CXCL2 and chemokine receptors CXCR4 
and CCR7 (Bruniquel and Schwartz 2003, Mori, Kim et al. 2005, Murayama, Sakura et 
al. 2006, Ramos, Grochoski et al. 2011, Fischer, Onur et al. 2012). Moreover, the 
regulation of IL-6 requires the cross-talk between different epigenetic players including 
TET2 to regulate DNA methylation and HDAC2 to modulate histone acetylation, a 
process that reduces inflammation by repression of IL-6 in macrophages (Zhang, Zhao 
et al. 2015). 
Microglia activation may also be dependent on histone modifications. Suh et al. 
showed that treatment with histone deacetylase inhibitors (HDACi) decreases the 
release of cytokines, including TNFα, IL-10, IL-1α and IL-6 suggesting that histone 
modifications may repress the microglial immune responses (Suh, Choi et al. 2010). 
More recently, using a mouse model where knock down of Hdac1 and Hdac2 was 
specifically directed to microglia, Datta et al. demonstrated that while these enzymes 
are not required for the survival of adult microglia in the normal brain, the deletion of 
Hdac1 and Hdac2 in the context of AD pathology increases the phagocytic activity of 
microglia, reducing amyloid plaques and cognitive decline (Datta, Staszewski et al. 
2018). 
Datta et al. also investigated the effects of prenatal ablation of HDACs, taking 
advantage of their inducible model. Interestingly, the lack of these histone-modifying 
enzymes early in life alters microglial proliferation and increases apoptosis, likely due to 
activation of cell death-signaling pathways at the transcriptional level (Datta, Staszewski 
et al. 2018). In a similar context, prenatal exposure to HDACi valproic acid results in 
higher density of microglia as well as modification of histones, further suggesting that 
modulation of histone changes directly affects microglia abundance (Kazlauskas, 
Campolongo et al. 2016). This epigenetic cascade seems to propagate across CNS cell 
types: activated microglia induce histone deacetylation in astrocytes reducing 
glutathione (GSH) transcription (Correa, Mallard et al. 2011). Low levels of GSH, in turn, 
trigger inflammatory molecules such as TNF-α, IL-6 and also stimulate kinase pathways 
further exacerbating the inflammatory state in neurodegenerative disorders (Lee, Cho et 
al. 2010, Pocernich and Butterfield 2012). 
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A more recent study supports the notion that immune memory in macrophages is 
executed by epigenetic alterations. Changes in histone methylation (H3K4me1) and 
acetylation (H3K27ac) associate with activation of enhancers that modulate 
inflammation-related genes. Notably, this study demonstrated that peripheral 
inflammation induces epigenetic remodeling in brain-resident microglia which then 
become tolerant to further inflammatory stimuli for at least 6-months, a phenomenon 
that alleviates amyloidosis in a mouse model of AD (Wendeln, Degenhardt et al. 2018). 
These results support the role of ELS-induced microglial memory in shaping the 
trajectory of AD pathology in later life. 
 
Epigenetic modulation of microglial memory due to psychological and nutritional stress 
Epigenetic mechanisms also mediate the effects of maternal behavior modulating 
microglial responses in the offspring’s brain. Increased maternal care stimulates the 
expression of IL-10 in newborn rats in a model of drug addiction. The effect, mediated 
by a reduction in IL-10-promoter methylation, appears to be specific to microglia. 
Elevated IL-10 is sustained throughout adulthood in the Nucleus accumbens and 
reduces microglial reactivity after drug exposure preventing reinstatement of morphine 
addiction in adult animals (Schwarz, Hutchinson et al. 2011). While this study was 
focused on a different paradigm, it provides another example on how epigenetic 
remodeling is a likely mediator of early life experience that can modulate microglial 
responses and disease risk in later life. Future studies in animal models and human 
cohorts may identify epigenetic biomarkers of ELS that predict increased risk to 
neurodegenerative diseases in adult life. 
Chronic stress may impact negatively the dietary choices (Yau and Potenza 
2013), so the impact of diet on neurodegeneration is important to consider in the 
present context. Diet also has crucial roles in shaping the early life environment, and the 
consequences of malnutrition or dietary deficiency may be long-lasting. For example, 
maternal immune activation due to exposure to inflammatory stimuli induces persistent 
changes in the fatty acid composition of the fetal brain. These alterations in 
neurodevelopment are associated with a reduction in the levels of n-3 polyunsaturated 
fatty acids (e.g., omega-3) in the offspring that are manifested later in life as memory 
and behavioral impairments (Labrousse, Leyrolle et al. 2018, Yam, Schipper et al. 
2019).   
Similarly, zinc deprivation associated with malnutrition, ageing or disease 
induces the production of pro-inflammatory cytokines IL-1β and TNF-α involving both, 
redox-dependent mechanisms and chromatin rearrangements (Wessels, Haase et al. 
2013). Still, more research is needed to determine whether zinc deficiency during early 
life is another factor that primes microglia for hyperactivation in later life.  
Homocysteine (Hcy) is another metabolite regulated by diet and associated with 
neurodegeneration. Hcy is a byproduct of the one-carbon metabolism pathway which 
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produces the methyl groups incorporated into DNA or proteins by conversion of SAM 
(S-adenosyl methionine) into SAH (S-adenosyl homocysteine). High levels of Hcy inhibit 
DNA-methyl transferase enzymes affecting the epigenome and the transcriptome and 
also impacting the responses to oxidation and inflammation (Ducker and Rabinowitz 
2017). Increased Hcy levels have been associated with AD and PD progression 
(Christine, Auinger et al. 2018, Baroni, Bonetto et al. 2019) and importantly, can 
influence the transition from cognitive impairment into dementia (Reitz, Tang et al. 2009, 
Blasko, Hinterberger et al. 2012). Since the levels of Hcy in healthy subjects are 
primarily determined by dietary intake of methionine, folate and vitamin B12; early life 
nutritional stress may prime the organism for neurological disease (Moretti and Caruso 
2019). Hcy induces proliferation and activation of microglia in vitro and increases 
oxidative stress and microgliosis in rodent models (Zou, Zhao et al. 2010). Furthermore, 
Li et al. showed that hyperhomocysteinemia induced in mice by supplementation with 
methionine, increases the level of inflammation markers TNFD and IL-1E in plasma, 
along with changes in the expression of cystathionine J-lyase (CSE) in macrophages. 
Importantly, in vitro testing showed that these alterations were mediated by epigenetic 
changes - namely increased DNA methylation at CSE promoter - and may serve as a 
form of macrophage memory (Li, Li et al. 2015). Hcy was implicated in chronic stress-
induced Aβ protein accumulation due to APP misprocessing and with cognitive decline 
in adult rats further supporting the role of Hcy in AD via solely dietary or stress-triggered 
signaling cascades (Xie, Zhao et al. 2016). More research is needed to understand the 
potential impact of imbalanced micronutrient intake and its interplay with stress 
exposures during early life on Hcy metabolism and whether this early insult will sustain 
long-lasting deleterious effects in the brain via microglial priming.  
 
7. Can early-life programing of microglia be reversed? Looking for new 
therapeutic targets. 
 
While an adverse prenatal environment seems to increase the risk for 
neurodegeneration in later life, exposure to an enriched environment (EE) during early 
life may reduce the odds of neurodegeneration. Furthermore, this mechanism is 
mediated by microglia. EE is known to induce neurogenesis (Clemenson, Lee et al. 
2015), and some studies suggest that EE can impact the number of microglia in cortex 
and hippocampus, also affecting their inflammatory and phagocytic activity (Williamson, 
Chao et al. 2012). A recent study showed that EE can modulate microglia in the dentate 
gyrus reducing the inflammatory response of microglia after exposure to AE oligomers 
(Xu, Gelyana et al. 2016). Not surprisingly, EE-associated behavior reduces chronic 
stress, a pathway we invoked repeatedly in this review as the likely common culprit of 
multi-hit etiology which manifests a disease susceptibility into a clinical 
neurodegenerative phenotype. 
 17 
Early life malnutrition may have a deleterious impact on the brain by increasing 
inflammation, but its mechanism of action also opens another opportunity for 
intervention. Manipulation of dietary intake of folate and omega-3 seems to reduce the 
effects of ELS on memory and cognition. For instance, manipulation of the ratios of 
long-chain polyunsaturated fatty acids in the dietary intake serves to increase the 
availability of omega-3 and has protective effects against ELS-associated cognitive 
impairment via modulation of microglia in the hippocampus (Yam, Schipper et al. 2019).  
Importantly, international consensus was recently reached in declaring elevated 
plasma levels of Hcy as a modifiable risk factor for dementia in the elderly. This factor 
has a population attributable risk that ranges from 4.1% to 30% and can be safely 
treated by supplementation with vitamin B (Smith, Refsum et al. 2018). Moreover, a 
recent study by Velazquez et al. reported beneficial effects of maternal choline 
supplementation in reducing Hcy levels in the offspring. Hcy reduction was associated 
with amelioration of AD pathology in transgenic mice models, including reduction of AE 
aggregates and microgliosis and improvement in cognitive function. The most 
remarkable finding of this study is that the benefits of diet manipulation extended across 
generations, and animals that were never exposed to choline supplementation but were 
born from the offspring of treated parents, still benefited from the intervention and 
showed a milder AD phenotype (Velazquez, Ferreira et al. 2019). Taking in all, these 
results suggest that early life dietary interventions may potentially revert adverse 
environmental cues, a mechanism that may be associated with microglial memory and 
epigenetic remodeling.     
Pioneering work by Ben Barres and Beth Stevens labs highlighted the role of the 
complement pathway in the microglial-neuronal interactions which make the brain more 
vulnerable to AD over time (Schafer, Lehrman et al. 2012, Hong, Beja-Glasser et al. 
2016). Similar signaling pathways, particularly the iron homeostasis pathway, mediate 
microglial memory of many different in utero insults; even when the adverse event is 
clinically asymptomatic (Cortes, Cao et al. 2017). Hyperactive microglia may prevent 
synaptogenesis thus predisposing to AD in later life (Stephan, Barres et al. 2012, Hong, 
Beja-Glasser et al. 2016). In primary fetal ovine microglia cultures, agonistic stimulation 
of the α7nACh receptor up-regulated C3AR1 (Cortes, Cao et al. 2017). These findings 
warrant further investigation as pro-cholinergic drugs are used in the treatment of AD 
symptoms although the consequences of cholinergic stimulation on microglial signaling 
are not yet well understood. Will selective blocking rather than enhancing α7nAChR 
signaling in microglia be potentially more beneficial for mitigating the AD progression by 
reducing the pace of synaptic degradation? 
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8. Conclusions 
 
We provide evidence supporting the role of early life programming in the 
susceptibility for adult neurodegenerative diseases while highlighting questions and 
proposing avenues for future research to advance our understanding of this 
fundamental process. The key elements of this phenomenon are chronic stress, 
neuroinflammation triggering microglial polarization, microglial memory and their 
connection to neurodegeneration.  
While this review focused on microglia, a full understanding of brain 
programming predisposing to neurodegenerative diseases will require incorporation of 
astrocytes and oligodendroglia and their dynamic interactions with microglia and 
neuronal cells (Hong, Beja-Glasser et al. 2016, Liddelow, Guttenplan et al. 2017, Dutta, 
Woo et al. 2018). 
We synthesize the reviewed mechanisms in Figure 1 which integrates the 
compounded impact of PS as well as the accompanying and independently occurring 
systemic and neuroinflammation on the glial energy reserves. The evolving metabolic 
phenotype of the stressed brain may represent the bottleneck substrate of the 
emergent, inherited and acquired resilience phenotype which, in turn, over multiple, 
subclinical hits with PS and/or inflammation modulates the progression of 
immunosenescence and the risk for neurodegeneration. Such framework offers a 
number of opportunities for early therapeutic interventions with long-term health benefits 
reducing the risk for neurodegeneration by modulating microglial immunometabolism. 
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Figure legends 
 
Figure 1. Spatiotemporal integration of prenatal stress and the accompanying or 
independently occurring systemic- and neuro-inflammation on glial energy reserves that 
may modulate the risk for neurodegeneration via modulation of the pace or extent of 
immunosenescence.  
 
(1), maternal-fetal circulation as an example of the interface for stress or 
inflammation/infection transfer of endogenous or exogenous biological mediators such 
as stress hormones, cytokines, bacteria or viruses (other interfaces are known for 
transfer of maternal exposures onto the fetus such as direct bacterial ascension into the 
fetal compartment or maternal-fetal heart rate entrainment which is likely biophysical). 
These factors induce or modulate changes in microglia in the fetal brain mediated by  
epigenetic changes (2).  
(3), cogwheel representation of interlocking, spatiotemporally (across organs/systems 
and during fetal/child growth and adulthood) distributed effectors which together shape 
the individual phenotype of the adult brain 
(4), over a sequence of repetitive, potentially asymptomatic modifications in (1) - (3); 
child and adult neuro- and glial development are shaped with variable degrees of 
susceptibility to neurodegeneration.
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